Key result
Venoarterial extracorporeal membrane oxygenation and septal reduction led to full recovery in a patient with hypertrophic cardiomyopathy and cardiogenic shock due to takotsubo cardiomyopathy.
Why the study?
Hemodynamic support in hypertrophic cardiomyopathy and cardiogenic shock is challenging because inotropes worsen intraventricular obstruction, and the effect of appropriate mechanical support remains undefined.
Case Report (n=1)
VA-ECMO combined with septal reduction can be a successful strategy for managing cardiogenic shock in patients with hypertrophic cardiomyopathy and concurrent Takotsubo cardiomyopathy.
VA-ECMO with septal reduction may aid recovery in HCM-takotsubo shock; leaves open optimal support strategies for prospective validation.
Providing hemodynamic support for patients with hypertrophic cardiomyopathy and cardiogenic shock can be challenging because inotropic medications worsen intraventricular obstruction, and the effect of appropriate mechanical support remains undefined. We report a patient with hypertrophic cardiomyopathy in shock because of takotsubo cardiomyopathy requiring venoarterial extracorporeal membrane oxygenation and septal reduction for full recovery. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Husaini et al. (2020) conducted a case report in Hypertrophic cardiomyopathy, takotsubo cardiomyopathy, cardiogenic shock (n=1). Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and septal reduction was evaluated on Full recovery. Venoarterial extracorporeal membrane oxygenation and septal reduction led to full recovery in a patient with hypertrophic cardiomyopathy and cardiogenic shock due to takotsubo cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: